DAFNA Capital Management’s Sutro Biopharma STRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$312K	Hold	437,079	–	–	0.09%	71
2025 Q1	$284K	Hold	437,079	–	–	0.08%	77
2024 Q4	$804K	Buy	437,079 +107,500	+33%	+$198K	0.2%	65
2024 Q3	$1.14M	Hold	329,579	–	–	0.27%	60
2024 Q2	$966K	Sell	329,579 -4,500	-1%	-$13.2K	0.23%	62
2024 Q1	$1.89M	Buy	334,079 +51,000	+18%	+$288K	0.43%	47
2023 Q4	$1.21M	Hold	283,079	–	–	0.29%	58
2023 Q3	$982K	Buy	283,079 +40,300	+17%	+$140K	0.31%	57
2023 Q2	$1.13M	Buy	242,779 +158,079	+187%	+$735K	0.31%	50
2023 Q1	$391K	Buy	+84,700	New	+$391K	0.12%	63
2022 Q4	–	Sell	-81,200	Closed	-$451K	–	84
2022 Q3	$451K	Sell	81,200 -3,500	-4%	-$19.4K	0.12%	73
2022 Q2	$441K	Hold	84,700	–	–	0.12%	78
2022 Q1	$696K	Buy	84,700 +39,700	+88%	+$326K	0.18%	78
2021 Q4	$670K	Sell	45,000 -40,000	-47%	-$596K	0.17%	76
2021 Q3	$1.61M	Hold	85,000	–	–	0.43%	55
2021 Q2	$1.58M	Hold	85,000	–	–	0.33%	58
2021 Q1	$1.94M	Hold	85,000	–	–	0.46%	52
2020 Q4	$1.85M	Sell	85,000 -33,940	-29%	-$737K	0.55%	40
2020 Q3	$1.2M	Buy	118,940 +12,496	+12%	+$126K	0.39%	53
2020 Q2	$826K	Buy	106,444 +66,444	+166%	+$516K	0.24%	64
2020 Q1	$408K	Hold	40,000	–	–	0.17%	68
2019 Q4	$440K	Hold	40,000	–	–	0.15%	73
2019 Q3	$364K	Buy	40,000 +8,506	+27%	+$77.4K	0.14%	76
2019 Q2	$358K	Hold	31,494	–	–	0.13%	75
2019 Q1	$359K	Hold	31,494	–	–	0.15%	68
2018 Q4	$284K	Buy	31,494 +4,000	+15%	+$36.1K	0.14%	72
2018 Q3	$412K	Buy	+27,494	New	+$412K	0.17%	62